Hörmann, A.A.; Schweighofer-Zwink, G.; Rendl, G.; Türk, K.; Nadeje, S.; Haas, K.; Jung, T.; Huber-Schönauer, U.; Hehenwarter, L.; Beheshti, M.;
et al. [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma. Pharmaceuticals 2024, 17, 1141.
https://doi.org/10.3390/ph17091141
AMA Style
Hörmann AA, Schweighofer-Zwink G, Rendl G, Türk K, Nadeje S, Haas K, Jung T, Huber-Schönauer U, Hehenwarter L, Beheshti M,
et al. [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma. Pharmaceuticals. 2024; 17(9):1141.
https://doi.org/10.3390/ph17091141
Chicago/Turabian Style
Hörmann, Anton Amadeus, Gregor Schweighofer-Zwink, Gundula Rendl, Kristina Türk, Samuel Nadeje, Kristina Haas, Theresa Jung, Ursula Huber-Schönauer, Lukas Hehenwarter, Mohsen Beheshti,
and et al. 2024. "[68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma" Pharmaceuticals 17, no. 9: 1141.
https://doi.org/10.3390/ph17091141
APA Style
Hörmann, A. A., Schweighofer-Zwink, G., Rendl, G., Türk, K., Nadeje, S., Haas, K., Jung, T., Huber-Schönauer, U., Hehenwarter, L., Beheshti, M., & Pirich, C.
(2024). [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma. Pharmaceuticals, 17(9), 1141.
https://doi.org/10.3390/ph17091141
